# Mass Balance Study of [14C] LPM3770164 in Healthy Participants

> **NCT07516899** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Luye Pharma Group Ltd.** · enrollment: 8 (estimated)

## Conditions studied

- Huntington Disease

## Interventions

- **DRUG:** [14C] LPM3770164

## Key facts

- **NCT ID:** NCT07516899
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516899, "Mass Balance Study of [14C] LPM3770164 in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07516899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*